This paper discusses how mesenchymal stem cells and their derived exosomes can serve as immunomodulatory agents — therapies that help rebalance the immune system. This is critical for treating autoimmune, inflammatory, and immune-related disorders.

The article supports the use of MSCs and exosomes in patients whose conditions are driven by immune dysfunction, offering a regenerative approach to immune health.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.